Venlafaxine Hydrochloride Tablet, Extended Release
Product Images NDC 64980-581

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 64980-581). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Venlafaxine-label01 (Venlafaxine Label01)

Venlafaxine-label01 (Venlafaxine Label01)
This is a medication called Venlafaxine which is available in the form of extended-release tablets containing 37.5 mg of Venlafaxine hydrochloride, manufactured by Unique Pharmaceutical Laboratories. It is recommended to dispense the accompanying medication guide to each patient. The usual dosage is once daily, and dosage information can be found in the package insert. The medication should be stored at 25°C (77°F) with excursions permitted to 15°- 30°C (50°- 86°F) and protected from moisture and humidity. The manufacturer's license number is G/1430, and the medication was issued in December 2022.*
FDA Label Image

Venlafaxine-label02 (Venlafaxine Label02)

FDA Label Image

Venlafaxine-label03 (Venlafaxine Label03)

Venlafaxine-label03 (Venlafaxine Label03)
FSRising NDC 64980-580-03 is a medication containing Venlafaxine in extended-release tablets. Each tablet is equivalent to 150mg of Venlafaxine and is usually taken once daily. The medication should be stored at 25°C (77°F) with excursions permitted to 15° - 30°C (50° - 86°F). The medication guide should be dispensed to each patient. It is manufactured by Unique Pharmaceutical Laboratories, a division of J.B. Chemicals & Pharmaceuticals Ltd. and distributed by Rising Pharmaceuticals Inc. at East Brunswick, NJ 08816. The manufacturing license number is G/1430 issued on 12/2022.*
FDA Label Image

Venlafaxine-label04 (Venlafaxine Label04)

Venlafaxine-label04 (Venlafaxine Label04)
FSRising NDC 64980-581-03 is a medication containing Venlafaxine Extended-Release Tablets manufactured by Unique Pharmaceutical Laboratories. Each extended-release tablet consists of 225mg of venlafaxine hydrochloride, USP. The usual dosage is once daily, and the package insert should be consulted for dosage information. The medication guide should be dispensed to each patient. Store at a temperature range of 15° - 30°C (50° - 86° F) in a moisture-free environment. It is distributed by Rising Pharmaceuticals, Inc., located in East Brunswick, NJ. The manufacturing license number is G/1430, and it was issued in December 2022.*
FDA Label Image

Venlafaxine-structure (Venlafaxine Structure)

Venlafaxine-structure (Venlafaxine Structure)
This text is a partially understandable chemical formula and a drug name "Venlafaxine hydrochloride".*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.